Synthesis, in vitro and in vivo evaluation of

5-HT1A receptor Carbon-11 PET Serotonin α1-adrenergic receptor

Journal

EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628

Informations de publication

Date de publication:
19 May 2020
Historique:
received: 11 02 2020
accepted: 23 04 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 21 5 2020
Statut: epublish

Résumé

Serotonin 1A (5-HT Syntheses of 1-3 and corresponding precursors for radiolabeling were achieved from isonicotinic, picolinic acid or picolino nitrile. In vitro binding studies demonstrated nanomolar affinity of the compounds for 5-HT Despite efficient radiolabeling, results from PET imaging experiments limit the application of [

Sections du résumé

BACKGROUND BACKGROUND
Serotonin 1A (5-HT
RESULTS RESULTS
Syntheses of 1-3 and corresponding precursors for radiolabeling were achieved from isonicotinic, picolinic acid or picolino nitrile. In vitro binding studies demonstrated nanomolar affinity of the compounds for 5-HT
CONCLUSION CONCLUSIONS
Despite efficient radiolabeling, results from PET imaging experiments limit the application of [

Identifiants

pubmed: 32430632
doi: 10.1186/s41181-020-00096-8
pii: 10.1186/s41181-020-00096-8
pmc: PMC7237647
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13

Subventions

Organisme : NIH HHS
ID : R01AG054473
Pays : United States

Références

J Comp Neurol. 2016 May 1;524(7):1457-71
pubmed: 26509362
Biol Psychiatry. 1999 Nov 15;46(10):1375-87
pubmed: 10578452
Eur J Med Chem. 2016 Mar 3;110:133-50
pubmed: 26820556
Neuropharmacology. 1999 Aug;38(8):1083-152
pubmed: 10462127
Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76
pubmed: 17971260
J Comput Aided Mol Des. 2013 Apr;27(4):305-19
pubmed: 23625023
Neuroimage. 1997 Nov;6(4):279-87
pubmed: 9417971
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
pubmed: 9345505
J Neurochem. 1986 Oct;47(4):1295-301
pubmed: 3018166
Nucl Med Biol. 2002 May;29(4):375-87
pubmed: 12031872
Neurochem Int. 1997 Jun;30(6):565-74
pubmed: 9152998
Mov Disord. 2012 Jan;27(1):84-9
pubmed: 21994070
J Nucl Med. 2010 Dec;51(12):1892-900
pubmed: 21098796
Neuropsychopharmacology. 2004 Dec;29(12):2258-65
pubmed: 15483563
Synapse. 2011 Jul;65(7):592-600
pubmed: 21484878
Synapse. 2013 Sep;67(9):596-608
pubmed: 23504990
J Med Chem. 2011 May 26;54(10):3480-91
pubmed: 21520940
Brain. 2004 Apr;127(Pt 4):900-13
pubmed: 14985263
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):702-7
pubmed: 16407119
Synapse. 2006 Dec 1;60(7):510-20
pubmed: 16952161
Curr Pharm Des. 2006;12(20):2473-86
pubmed: 16842171
Brain Res. 1989 Nov 6;501(2):287-94
pubmed: 2555022
Brain Res. 1995 Mar 6;673(2):217-25
pubmed: 7606435
Prog Brain Res. 2008;172:233-64
pubmed: 18772036
Pharmacol Biochem Behav. 1985 May;22(5):859-74
pubmed: 2989949
Appl Radiat Isot. 2014 Jul;89:141-5
pubmed: 24631746
Eur J Med Chem. 2012 Jan;47(1):520-9
pubmed: 22133459
Biol Psychiatry. 2005 Dec 15;58(12):947-54
pubmed: 16039621
Int Rev Neurobiol. 2018;141:173-210
pubmed: 30314596
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1050-60
pubmed: 17221184
Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112
pubmed: 25360773
Brain Res. 1997 Jan 16;745(1-2):96-108
pubmed: 9037397
Am J Psychiatry. 2006 Jan;163(1):52-8
pubmed: 16390889
Appl Radiat Isot. 2009 Jan;67(1):73-8
pubmed: 18715791
Brain Res. 2013 Apr 24;1507:11-8
pubmed: 23454434
Eur J Nucl Med. 1998 Apr;25(4):338-46
pubmed: 9553162
Synapse. 2007 Jul;61(7):469-77
pubmed: 17415792
J Med Chem. 2006 Jan 12;49(1):125-34
pubmed: 16392798
Nucl Med Biol. 1996 Jul;23(5):627-34
pubmed: 8905828
J Nucl Med. 2002 Mar;43(3):292-303
pubmed: 11884487
Arch Gen Psychiatry. 2000 Feb;57(2):174-80
pubmed: 10665620
J Neurochem. 1992 Apr;58(4):1338-46
pubmed: 1548468
Synapse. 1997 Feb;25(2):147-54
pubmed: 9021895
Trends Pharmacol Sci. 2009 Aug;30(8):431-40
pubmed: 19616318
Neuroimage. 2006 Aug 15;32(2):538-50
pubmed: 16784876
Mol Imaging. 2003 Jul;2(3):131-7
pubmed: 14649056
Neurochem Int. 1985;7(6):1061-72
pubmed: 20493020
Neuropharmacology. 2007 Mar;52(3):695-707
pubmed: 17101155
J Nucl Med. 2014 Jan;55(1):141-6
pubmed: 24385311
J Comp Neurol. 1985 Jan 8;231(2):190-208
pubmed: 2981906
Brain Res. 1986 Jun 18;376(1):85-96
pubmed: 3719375
IEEE Trans Med Imaging. 1997 Apr;16(2):145-58
pubmed: 9101324
Psychopharmacology (Berl). 2006 Oct;188(2):244-51
pubmed: 16915381
Bioorg Med Chem. 2017 Oct 15;25(20):5820-5837
pubmed: 28943244

Auteurs

Vidya Narayanaswami (V)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.

Junchao Tong (J)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.

Ferdinando Fiorino (F)

Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy.

Beatrice Severino (B)

Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy.

Rosa Sparaco (R)

Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy.

Elisa Magli (E)

Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy.

Flavia Giordano (F)

Department of Pharmacy, University of Naples, Via D. Montesano, 49, 8013, Naples, Italy.

Peter M Bloomfield (PM)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.

Jaya Prabhakaran (J)

Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.

J John Mann (JJ)

Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA.
Department of Psychiatry, Columbia University Medical Center, New York, USA.

Neil Vasdev (N)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, M5T-1R8, Canada.

Kenneth Dahl (K)

Azrieli Centre for Neuro-Radiochemistry, Research Imaging Centre & Preclinical Imaging, Centre for Addiction and Mental Health, Toronto, Ontario, M5T-1R8, Canada. KennethF.Dahl@gmail.com.

J S Dileep Kumar (JSD)

Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, USA. Dileep.Kumar@nyspi.columbia.edu.

Classifications MeSH